![](/img/cover-not-exists.png)
Low-Dose Rituximab for Active Moderate-to-Severe Graves’ Orbitopathy Resistant to Conventional Treatment
Du Pasquier-Fediaevsky, Laurence, Andrei, Stefan, Berche, Michel, Leenhardt, Laurence, Héron, Emmanuel, Rivière, SébastienLanguage:
english
Journal:
Ocular Immunology and Inflammation
DOI:
10.1080/09273948.2018.1453078
Date:
April, 2018
File:
PDF, 437 KB
english, 2018